NYSE ARCA | ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments inU. S. and non-U.S. health care companies.
The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 8.75% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 8.71% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 6.49% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.55% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 4.80% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 4.73% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.69% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.71% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.55% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 3.42% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.33% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 3.01% |
| 7741 | Hoya Cor | Healthcare | Medical Instruments & Supplies | 2.96% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 2.89% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.85% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 2.73% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 2.72% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.71% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.69% |
| 0QIU | Novo Nordisk A/S Class B | 2.66% |